References
- Hobbs F, Stoops N. Demographic Trends in the 21st Century. Washington, DC:US Census Bureau, Census 2000 Special Reports, Series CENSR-4
- Cauley JA, Robbins J, Chen Z, et al Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729–1738
- Chlebowski RT, Hendrix SL, Langer RD, et al Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA 2003;289:3243–3253
- Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991–1004
- Cushman M, Kuller LH, Prentice R, et al Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573–1580
- Manson JE, Hsia J, Johnson KC, et al Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–534
- Rossouw JE, Anderson GL, Prentice RL, et al Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333
- Shumaker SA, Legault C, Rapp SR, et al Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651–2662
- Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E16–E25
- Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501–509
- Lo Presti A, Ruvolo G, Gancitano RA, Cittadini E. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol 2004; 113(Suppl 1):S33–S40
- North American Menopause Society. Menopause Practice: A Clinician's Guide. Cleveland, OH:North American Menopause Society, 2004
- Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006;99:215–220
- Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care 2007;45:431–439
- Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 2001;19:322–328
- Nelson HD, Vesco KK, Haney E, et al Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057–2071
- Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453–1465
- Carroll DG. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 2006;73:457–464
- Bruno D, Feeney KJ. Management of postmenopausal symptoms in breast cancer survivors. Semin Oncol 2006;33:696–707
- Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005;118(12 Suppl 2):98–108S
- Carpenter JS. State of the science: Hot flashes and cancer. Part 2: Management and future directions. Oncol Nurs Forum 2005;32:969–978
- Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes in women. J Support Oncol 2003;1:11–21
- Wymenga AN, Sleijfer DT. Management of hot flushes in breast cancer patients. Acta Oncol 2002;41:269–275
- Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280–4290
- US Department of Health and Human Services (DHHS). Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms – recommendations for clinical evaluation: Draft guidance. Rockville:Food and Drug Administration Center for Drug Evaluation and Research (CDER); January 2003
- Carpenter JS, Monahan PO, Azzouz F. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol 2004;104:1322–1326
- Sievert LL, Freedman RR, Garcia JZ, et al Measurement of hot flashes by sternal skin conductance and subjective hot flash report in Puebla, Mexico. Menopause 2002;9:367–376
- Savard J, Davidson JR, Ivers H, et al The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 2004;27:513–522
- Miller HG, Li RM. Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clin Proc 2004;79:777–781
- Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979–989
- Carpenter JS, Andrykowski MA, Freedman RR, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999;6:209–215
- Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45(1 Spec No):5–13
- Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370
- Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003;1:29
- Jacobsen PB, Donovan KA, Trask PC, et al Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:1494–1502
- Carpenter JS, Andrykowski MA, Wilson J, et al Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs 1998;19:481–494
- Radloff IS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psych Meas 1977;1:385–401
- McCallum J, Mackinnon A, Simons L, Simons J. Measurement properties of the Center for Epidemiological Studies Depression Scale: an Australian community study of aged persons. J Gerontol B Psychol Sci Soc Sci 1995;50:S182–S189
- Coyle CP, Roberge J. The psychometric properties of the Center for Epidemiological Studies-Depression Scale (CES-D) when used with physical disabilities. Psychol Health 1992;7:69–81
- LISREL [computer program]. Version 8.8. Chicago:Scientific Software International, 2008
- Little TD, Cunningham WA, Shahar G, Widaman KF. To parcel or not to parcel: exploring the question, weighing the merits. Structural Equation Modeling 2002;9:151–173
- Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behavioral Res 1990;25:173–180
- Browne MW, Cudeck, R. Alternative ways of assessing model fit. In Bollen KA, Long JS, eds. Testing Structural Equation Models. Newbury Park, CA:Sage, 1993:136–62
- Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999;6:1–55
- Enders CK. The performance of the full information maximum likelihood estimator in multiple regression models with missing data. Educat Psychol Measurement 2001;61:713–740
- Carpenter JS, Rand KL. Modeling the hot flash experience in breast cancer survivors. Menopause 2008; 15:469–475
- Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 2006;13:163–172
- Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nursing Forum 2005;32:542
- Affleck G, Tennen H, Zautra A, Urrows S, Abeles M, Karoly P. Women's pursuit of personal goals in daily life with fibromyalgia: a value-expectancy analysis. J Consult Clin Psychol 2001;69:587–596
- Brunstein JC. Personal goals and subjective well-being: a longitudinal study. J Personality Soc Psychol 1993;65:1061–1070
- Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52
- Young T, Rabago D, Zgierska A, Austin D, Finn L. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin sleep cohort study. Sleep 2003;26:673–677
- Polo-Kantola P, Erkkola R, Irjala K, Helenius H, Pullinen S, Polo O. Climacteric symptoms and sleep quality. Obstet Gynecol 1999;94:219–224
- Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005;65:927–947
- Carpenter JS, Azzouz F, Monahan PO, Storniolo AM, Ridner SH. Is sternal skin conductance monitoring a valid measure of hot flash intensity or distress? Menopause 2005;12:512–519
- Caltabiano ML, Holzheimer M. Dispositional factors, coping and adaptation during menopause. Climacteric 1999;2:21–28
- Carpenter JS, Gilchrist JM, Chen K, Gautam S, Freedman RR. Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause 2004;11:375–381
- Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332–337